Background Short-term treatment for people with type 2 diabetes using a low dose of the
selective endothelin A receptor antagonist atrasentan reduces albuminuria without causing …

Fasting during Ramadan is one of the five pillars of Islam and is obligatory for all healthy
Muslims from the age of puberty. Though individuals with some illness and serious medical …

Background Semaglutide is an effective treatment for type 2 diabetes; however, 20–30% of
patients given semaglutide 1·0 mg do not reach glycaemic treatment goals. We aimed to …

Background It is thought that a reduction in the frequency of basal insulin injections might
facilitate treatment acceptance and adherence among patients with type 2 diabetes. Insulin …

Background Canagliflozin reduced renal and cardiovascular events in people with type 2
diabetes in the CREDENCE trial. We assessed efficacy and safety of canagliflozin by initial …

Background Insulin icodec (icodec) is a basal insulin analogue suitable for once-weekly
dosing. ONWARDS 4 aimed to assess the efficacy and safety of once-weekly icodec compared …

OBJECTIVE The Dapagliflozin and Prevention of Adverse outcomes in Chronic Kidney Disease
(DAPA-CKD) study demonstrated risk reduction for kidney and cardiovascular outcomes …

Optimal glycemic control is fundamental to the management of diabetes. Regardless of the
underlying treatment, glycated hemoglobin (A1C) levels> 7.0% are associated with a …

Aim To examine the efficacy and patient satisfaction of intermittently scanned continuous
glucose monitoring (isCGM) in adults using non‐insulin therapies for the management of type 2 …

Aims/hypothesis A head-to-head randomised trial was conducted to evaluate hypoglycaemia
safety with insulin degludec 200 U/ml (degludec U200) and insulin glargine 300 U/ml (…